Featured Research

from universities, journals, and other organizations

Halving Daily Cigarette Quota Has No Health Benefit

Date:
November 29, 2006
Source:
BMJ Specialty Journals
Summary:
Halving the number of cigarettes smoked every day in the belief that it will stave off an early death makes no difference, suggests research in Tobacco Control. Although reducing consumption may have a place as a temporary measure in smoking cessation, this study proves quite clearly that the only safe way out of the risk caused by smoking is to quit, say the authors.

Halving the number of cigarettes smoked every day in the belief that it will stave off an early death makes no difference, suggests research in Tobacco Control.

Although reducing consumption may have a place as a temporary measure in smoking cessation, this study proves quite clearly that the only safe way out of the risk caused by smoking is to quit, say the authors.

They base their findings on more than 51,000 men and women, all of whom were aged between 20 and 34 at the start of the study.

Participants were initially assessed for cardiovascular risk factors, and then screened again twice at an interval of three to 10 years, adding up to an average monitoring period of over two decades.

Participants were classified as never smokers; ex smokers, quitters (those who gave up between the first and second check); moderate smokers (1 to 14 cigarettes daily); reducers (more than 15 cigarettes a day, cut by more than half at the second check); and heavy smokers (more than 15 cigarettes a day).

Among men, deaths from lung cancer and cancers associated with smoking were not significantly lower in those who had cut back compared with heavy smokers. But this was not true of women who cut back, where the reverse was true.

And men who cut back only had slightly lower death rates from all causes combined than the heavy smokers during the first 15 years. After that, death rates were comparable.

And there were no significant differences in death rates from specific causes, including early death from cardiovascular disease, among women who cut back their daily consumption, compared with those who continued to smoke heavily.

Women who cut back actually had higher death rates from all causes combined than heavy smokers.

The authors conclude that long term monitoring provides no evidence that heavy smokers, who halve their daily cigarette consumption, significantly cut their risk of early death. They add that people may be misled if they are advised that cutting back will help them stave off disease.


Story Source:

The above story is based on materials provided by BMJ Specialty Journals. Note: Materials may be edited for content and length.


Cite This Page:

BMJ Specialty Journals. "Halving Daily Cigarette Quota Has No Health Benefit." ScienceDaily. ScienceDaily, 29 November 2006. <www.sciencedaily.com/releases/2006/11/061128083939.htm>.
BMJ Specialty Journals. (2006, November 29). Halving Daily Cigarette Quota Has No Health Benefit. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2006/11/061128083939.htm
BMJ Specialty Journals. "Halving Daily Cigarette Quota Has No Health Benefit." ScienceDaily. www.sciencedaily.com/releases/2006/11/061128083939.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins